Statement from UniTao Pharmaceuticals, LLC March 20, 2015

Statement from UniTao Pharmaceuticals, LLC
March 20, 2015

Today, UniTao Pharmaceuticals, LLC (UniTao) announced plans to idle its pharmaceutical operations in Petersburg, Virginia, until business conditions improve. UniTao is expected to keep a small team on-site to ensure the facility remains a viable pharmaceutical operation in the near future. The impacted employees will receive a severance package for their brief service to the company.  UniTao has informed the Governor's office and the City of Petersburg that it will not be accepting the economic development grants offered by the state and the locality since the company cannot meet the obligations of those agreements at this time. 

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.